Disability & Neurodiversity

In this week's episode, Han is joined by Emily Nuttall. Emily is a mental health campaigner, and ambassador for BEAT and Mind. Emily is also advising at Action for Children.

In this week's episode, we discuss:

  • Emily's experience of an eating disorder.

  • The impact of having cerebral palsy on the development of Emily's eating disorder, and how this impacted her recovery.

  • The impact of having autism on the development of Emily's eating disorder, and how this impacted her recovery.

  • What Emily found useful in her treatment, and the importance of a multi-disciplinary approach which individualises treatment based on the patient, not the diagnosis.

  • Emily's awareness-raising work as an individual with lived experience.

To find out more about Emily, you can find her here:

Recent Posts

Supporting the Supporter with Harriet Parsons

By Hannah Hickinbotham • October 13, 2025
Eating disorders affect more than the individual, they impact the whole family.

Making Eating Disorder Services More Inclusive for Men with George Mycock

By Hannah Hickinbotham • October 6, 2025
Discover how George Mycock's research is reshaping eating disorder support for men. Learn why inclusive, person-centred resources matter — and how services can better reach men at every stage of their journey.

Neurodiversity, Eating Disorder Recovery & Burnout

By Hannah Hickinbotham • September 29, 2025
What happens when your eating disorder recovery is deeply intertwined with your neurodivergence?
Nightingale Hospital, London

Welcoming Welcome Nightingale Hospital as Our New Podcast Sponsor

By Hannah Hickinbotham • September 24, 2025
Nightingale Hospital is now sponsoring the Full of Beans podcast. Discover why their values align so deeply with ours and what this partnership means for the future.

Exploring the Impact of Autism Late Diagnosis on Eating Disorder Recovery

By Hannah Hickinbotham • September 21, 2025
Autism and anorexia might be related, but what happens if you don't know you're autistic?
Exploring the Risks of Unregulated Weight Loss Medications

Exploring the Risk of Unregulated Weight Loss Medications

By Hannah Hickinbotham • September 14, 2025
Unregulated access to GLP-1 weight-loss drugs poses serious risks—particularly for those with a history of eating disorders. Here's why regulation, screening, and support must be prioritised.
Show More